Axillary lymph node failure in patients treated with accelerated partial breast irradiation

Cancer

Volumn 118, Issue 1, 2012, Pages 38-43

  Dekhne, Nayana ^a   Shah, Chirag ^b   Wilkinson, J Ben ^b   Mitchell, Christina ^b   Chen, Peter ^b   Margolis, Jeffrey ^b   Vicini, Frank ^b  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

accelerated partial breast irradiation; axillary failure; breast cancer; breast conservation therapy; regional lymph node failure

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ESTROGEN RECEPTOR;

ACCELERATED PARTIAL BREAST IRRADIATION; ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; BRACHYTHERAPY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; PARTIAL BODY RADIATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL TIME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; THERAPEUTICS;

EID: 83855162907     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26305     Document Type: Article

References (22)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 1233-1241. (Pubitemid 35176242)
2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 1227-1232. (Pubitemid 35176241)
3. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 2087-2106. (Pubitemid 41797643)
4. Vinh-Hung V, Verschraegen C,. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004; 96: 115-121. (Pubitemid 38195902)
5. Arthur DW, Vicini FA, Kuske RR, Wazer DE, Nag S,. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy. 2003; 2: 124-130. (Pubitemid 36960130)
6. Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A,. Limited-field radiation therapy in the management of early stage breast cancer. J Natl Cancer Inst. 2003; 95: 1205-1210.
7. Benitez PR, Keisch ME, Vicini F, et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early stage breast cancer. Am J Surg. 2007; 19: 456-462. (Pubitemid 47370993)
8. Chen PY, Wallace M, Mitchell C, et al. Four-year efficacy, cosmesis, and toxicity using 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010; 76: 991-997.
9. Smith GL, Xu Y, Buchholz TA, et al. Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol. 2011; 29: 157-165.
10. Reznik J, Cicchetti MG, Degaspe B, Fitzgerald TJ,. Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys. 2005; 61: 163-168. (Pubitemid 40039118)
11. Nelson JC, Beitsch PD, Vicini FA, et al. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Am J Surg. 2009; 198: 83-91.
12. Vicini F, Winter K, Wong J, et al. Initial efficacy results of RTOG 0319: 3-dimensional conformal radiation therapy (3-D CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys. 2010; 77: 1120-1127.
13. Vicini F, Arthur D, Wazer D, et al. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011; 79: 977-984.
14. Beitsch P, Vicini F, Keisch M, et al. Five-year outcome of patients classified in the "unsuitable" category using the American Society of Therapeutic Radiology and Oncology (ASTRO) Consensus Panel guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry trial. Ann Surg Oncol. 2010; 17 (suppl 3): 219-225.
15. Wilkinson JB, Reed RE, Wallace MF, et al. Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast irradiation [published online ahead of print February 22, 2011]. Int J Radiat Oncol Biol Phys. 2011.
16. van Wely BJ, Teerenstra S, Schinagl DA, Aufenacker TJ, De Wilt JH, Strobbe LJ,. Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy. Br J Surg. 2011; 98: 326-333.
17. Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in 5 National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009; 27: 2466-2473.
18. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010; 252: 426-432; discussion 432-443.
19. Konkin DE, Tyldesley S, Kennecke H, Speers CH, Olivotto IA, Davis N,. Management and outcomes of isolated axillary node recurrence in breast cancer. Arch Surg. 2006; 141: 867-872; discussion 872-874. (Pubitemid 44414430)
20. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in 5 National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006; 24: 2028-2037. (Pubitemid 46622111)
21. Newman LA, Hunt KK, Buchholz T, et al. Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg. 2000; 180: 252-256.
22. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011; 305: 569-575.